Delivery Order SPE2DB20D1050-SPE2DB24FH65U
Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,904.70 firm-fixed-price delivery order is for the supply of BOOSTRIX TDAP vaccine syringes. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,850.00 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP vaccine syringes (0.5 mL). The contract has an ultimate completion date of December 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The $2,554.30 firm fixed price contract has an ultimate completion date of November 4, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,682.02 delivery order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance through January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $7,319.00 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 8, 2024 with a completion date of July 9, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $33,555.84 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,564,353 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a ceiling value of $36,781.92 and an ultimate completion date of April 23, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,052.50, is for the delivery of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of November 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Boostrix TDAP vaccine syringes. The contract has a ceiling value of $1,031.16 and a period of performance through July 1, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,661.00 firm fixed-price delivery order is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support federal healthcare programs. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...